LifeMD, Inc. (NASDAQ: LFMDP) Stock Competitors & Peer Comparison
See LFMDP's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for LFMDP and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LFMDP | $23.17 | -0.02% | 158.2M | -714.95 | -$0.03 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| TEM | $72.69 | +9.06% | 12.7B | -145.38 | -$0.50 | N/A |
| BTSG | $58.87 | -1.11% | 11.6B | 47.48 | $1.24 | N/A |
| BTSGU | $194.37 | -1.05% | 11.5B | 176.26 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $105.41 | +1.09% | 8.8B | 24.63 | $4.28 | N/A |
| TXG | $65.12 | +1.96% | 8.3B | -110.37 | -$0.59 | N/A |
| HNGE | $88.42 | +3.27% | 6.8B | 47.29 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
LFMDP vs GEHCV Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas GEHCV's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, LFMDP is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check GEHCV's competition here
Tempus AI, Inc. (NASDAQ: TEM)
LFMDP vs TEM Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, TEM has a market cap of 12.7B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while TEM trades at $72.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas TEM's P/E ratio is -145.38. In terms of profitability, LFMDP's ROE is -1.79%, compared to TEM's ROE of -0.55%. Regarding short-term risk, LFMDP is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check TEM's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
LFMDP vs BTSG Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, BTSG has a market cap of 11.6B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while BTSG trades at $58.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas BTSG's P/E ratio is 47.48. In terms of profitability, LFMDP's ROE is -1.79%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, LFMDP is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
LFMDP vs BTSGU Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, BTSGU has a market cap of 11.5B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while BTSGU trades at $194.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas BTSGU's P/E ratio is 176.26. In terms of profitability, LFMDP's ROE is -1.79%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, LFMDP is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
LFMDP vs SGFY Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SGFY's P/E ratio is 70.91. In terms of profitability, LFMDP's ROE is -1.79%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, LFMDP is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
LFMDP vs HQY Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while HQY trades at $105.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas HQY's P/E ratio is 24.63. In terms of profitability, LFMDP's ROE is -1.79%, compared to HQY's ROE of +0.11%. Regarding short-term risk, LFMDP is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
LFMDP vs TXG Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, TXG has a market cap of 8.3B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while TXG trades at $65.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas TXG's P/E ratio is -110.37. In terms of profitability, LFMDP's ROE is -1.79%, compared to TXG's ROE of -0.09%. Regarding short-term risk, LFMDP is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
LFMDP vs HNGE Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while HNGE trades at $88.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas HNGE's P/E ratio is 47.29. In terms of profitability, LFMDP's ROE is -1.79%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, LFMDP is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
LFMDP vs RCM Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas RCM's P/E ratio is -102.21. In terms of profitability, LFMDP's ROE is -1.79%, compared to RCM's ROE of +0.00%. Regarding short-term risk, LFMDP is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
LFMDP vs WAY Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, WAY has a market cap of 4.8B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while WAY trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas WAY's P/E ratio is 16.56. In terms of profitability, LFMDP's ROE is -1.79%, compared to WAY's ROE of +0.04%. Regarding short-term risk, LFMDP is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
LFMDP vs DOCS Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, DOCS has a market cap of 4.7B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while DOCS trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas DOCS's P/E ratio is 16.55. In terms of profitability, LFMDP's ROE is -1.79%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, LFMDP is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check DOCS's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
LFMDP vs HTFL Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while HTFL trades at $49.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas HTFL's P/E ratio is -24.75. In terms of profitability, LFMDP's ROE is -1.79%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, LFMDP is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
LFMDP vs ONEM Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas ONEM's P/E ratio is -7.77. In terms of profitability, LFMDP's ROE is -1.79%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, LFMDP is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
LFMDP vs PRVA Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while PRVA trades at $21.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas PRVA's P/E ratio is 100.57. In terms of profitability, LFMDP's ROE is -1.79%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, LFMDP is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
LFMDP vs PGNY Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while PGNY trades at $25.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas PGNY's P/E ratio is 26.44. In terms of profitability, LFMDP's ROE is -1.79%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, LFMDP is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check PGNY's competition here
Omnicell, Inc. (NASDAQ: OMCL)
LFMDP vs OMCL Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, OMCL has a market cap of 1.6B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while OMCL trades at $35.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas OMCL's P/E ratio is 18.63. In terms of profitability, LFMDP's ROE is -1.79%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, LFMDP is less volatile compared to OMCL. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check OMCL's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
LFMDP vs NXGN Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas NXGN's P/E ratio is -266.00. In terms of profitability, LFMDP's ROE is -1.79%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, LFMDP is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
LFMDP vs OMDA Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while OMDA trades at $23.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas OMDA's P/E ratio is 341.29. In terms of profitability, LFMDP's ROE is -1.79%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, LFMDP is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
LFMDP vs AGTI Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas AGTI's P/E ratio is -71.79. In terms of profitability, LFMDP's ROE is -1.79%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, LFMDP is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
LFMDP vs CERT Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CERT has a market cap of 1.4B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CERT trades at $8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CERT's P/E ratio is 21.83. In terms of profitability, LFMDP's ROE is -1.79%, compared to CERT's ROE of -0.07%. Regarding short-term risk, LFMDP is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
LFMDP vs GDRX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while GDRX trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas GDRX's P/E ratio is 10.78. In terms of profitability, LFMDP's ROE is -1.79%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, LFMDP is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
LFMDP vs TDOC Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while TDOC trades at $6.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas TDOC's P/E ratio is -6.46. In terms of profitability, LFMDP's ROE is -1.79%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, LFMDP is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
LFMDP vs CCLDO Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CCLDO's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, LFMDP is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
LFMDP vs HSTM Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, HSTM has a market cap of 843.4M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while HSTM trades at $28.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas HSTM's P/E ratio is 35.64. In terms of profitability, LFMDP's ROE is -1.79%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, LFMDP is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
LFMDP vs PHR Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, PHR has a market cap of 747.9M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while PHR trades at $12.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas PHR's P/E ratio is 43.21. In terms of profitability, LFMDP's ROE is -1.79%, compared to PHR's ROE of +0.03%. Regarding short-term risk, LFMDP is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
LFMDP vs SOPH Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SOPH has a market cap of 725.7M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SOPH trades at $8.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SOPH's P/E ratio is -7.79. In terms of profitability, LFMDP's ROE is -1.79%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, LFMDP is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
LFMDP vs MPLN-WT Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, LFMDP is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check MPLN-WT's competition here
Claritev Corporation (NYSE: CTEV)
LFMDP vs CTEV Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CTEV has a market cap of 578.8M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CTEV trades at $37.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CTEV's P/E ratio is -2.00. In terms of profitability, LFMDP's ROE is -1.79%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, LFMDP is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CTEV's competition here
Accolade, Inc. (NASDAQ: ACCD)
LFMDP vs ACCD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas ACCD's P/E ratio is -3.08. In terms of profitability, LFMDP's ROE is -1.79%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, LFMDP is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check ACCD's competition here
Evolent Health, Inc. (NYSE: EVH)
LFMDP vs EVH Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, EVH has a market cap of 533.2M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while EVH trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas EVH's P/E ratio is 36.46. In terms of profitability, LFMDP's ROE is -1.79%, compared to EVH's ROE of -0.99%. Regarding short-term risk, LFMDP is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check EVH's competition here
Sharecare, Inc. (NASDAQ: SHCR)
LFMDP vs SHCR Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SHCR's P/E ratio is -3.76. In terms of profitability, LFMDP's ROE is -1.79%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, LFMDP is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check SHCR's competition here
NRC Health (NASDAQ: NRC)
LFMDP vs NRC Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, NRC has a market cap of 500.1M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while NRC trades at $22.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas NRC's P/E ratio is 27.06. In terms of profitability, LFMDP's ROE is -1.79%, compared to NRC's ROE of +0.48%. Regarding short-term risk, LFMDP is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
LFMDP vs SLGC Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SLGC's P/E ratio is -3.04. In terms of profitability, LFMDP's ROE is -1.79%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, LFMDP is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
LFMDP vs SLGCW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, LFMDP's ROE is -1.79%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, LFMDP is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
LFMDP vs TBRG Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas TBRG's P/E ratio is 9.37. In terms of profitability, LFMDP's ROE is -1.79%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, LFMDP is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
LFMDP vs MPLN Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas MPLN's P/E ratio is -0.23. In terms of profitability, LFMDP's ROE is -1.79%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, LFMDP is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
LFMDP vs SY Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SY has a market cap of 300.5M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SY's P/E ratio is -6.94. In terms of profitability, LFMDP's ROE is -1.79%, compared to SY's ROE of -0.16%. Regarding short-term risk, LFMDP is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
LFMDP vs TRHC Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas TRHC's P/E ratio is -4.27. In terms of profitability, LFMDP's ROE is -1.79%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, LFMDP is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
LFMDP vs SMFR Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SMFR's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, LFMDP is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
LFMDP vs SPOK Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SPOK has a market cap of 215.3M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SPOK trades at $10.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SPOK's P/E ratio is 17.18. In terms of profitability, LFMDP's ROE is -1.79%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, LFMDP is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
LFMDP vs AMWL Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, AMWL has a market cap of 201.6M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while AMWL trades at $11.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas AMWL's P/E ratio is -2.68. In terms of profitability, LFMDP's ROE is -1.79%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, LFMDP is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check AMWL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
LFMDP vs LFMD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, LFMD has a market cap of 160.1M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while LFMD trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas LFMD's P/E ratio is -6.62. In terms of profitability, LFMDP's ROE is -1.79%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, LFMDP is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check LFMD's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
LFMDP vs OPRX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, OPRX has a market cap of 144.7M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while OPRX trades at $7.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas OPRX's P/E ratio is 7.07. In terms of profitability, LFMDP's ROE is -1.79%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, LFMDP is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
LFMDP vs CPSI Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CPSI's P/E ratio is -183.80. In terms of profitability, LFMDP's ROE is -1.79%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, LFMDP is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CPSI's competition here
Augmedix, Inc. (NASDAQ: AUGX)
LFMDP vs AUGX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas AUGX's P/E ratio is -4.99. In terms of profitability, LFMDP's ROE is -1.79%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, LFMDP is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check AUGX's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
LFMDP vs HCAT Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, HCAT has a market cap of 113.1M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while HCAT trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas HCAT's P/E ratio is 7.65. In terms of profitability, LFMDP's ROE is -1.79%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, LFMDP is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check HCAT's competition here
CareCloud, Inc. (NASDAQ: CCLD)
LFMDP vs CCLD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CCLD has a market cap of 111.8M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CCLD trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CCLD's P/E ratio is 10.12. In terms of profitability, LFMDP's ROE is -1.79%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, LFMDP is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
LFMDP vs WORX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas WORX's P/E ratio is -6.40. In terms of profitability, LFMDP's ROE is -1.79%, compared to WORX's ROE of -0.35%. Regarding short-term risk, LFMDP is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check WORX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
LFMDP vs DH Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, DH has a market cap of 75.4M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while DH trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas DH's P/E ratio is 2.75. In terms of profitability, LFMDP's ROE is -1.79%, compared to DH's ROE of -0.79%. Regarding short-term risk, LFMDP is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
LFMDP vs FORA Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas FORA's P/E ratio is -24.11. In terms of profitability, LFMDP's ROE is -1.79%, compared to FORA's ROE of -0.17%. Regarding short-term risk, LFMDP is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
LFMDP vs CCLDP Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CCLDP's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, LFMDP is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
LFMDP vs SNCE Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SNCE's P/E ratio is -0.27. In terms of profitability, LFMDP's ROE is -1.79%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, LFMDP is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check SNCE's competition here
OneMedNet Corporation (NASDAQ: ONMD)
LFMDP vs ONMD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, ONMD has a market cap of 34.2M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while ONMD trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas ONMD's P/E ratio is -3.75. In terms of profitability, LFMDP's ROE is -1.79%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, LFMDP is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check ONMD's competition here
Akili, Inc. (NASDAQ: AKLI)
LFMDP vs AKLI Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas AKLI's P/E ratio is -0.71. In terms of profitability, LFMDP's ROE is -1.79%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, LFMDP is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
LFMDP vs SHLT Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SHLT's P/E ratio is -3.87. In terms of profitability, LFMDP's ROE is -1.79%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, LFMDP is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
LFMDP vs SHCRW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, LFMDP's ROE is -1.79%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, LFMDP is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
LFMDP vs ONMDW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, ONMDW has a market cap of 27.9M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas ONMDW's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, LFMDP is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
LFMDP vs STRM Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas STRM's P/E ratio is -2.40. In terms of profitability, LFMDP's ROE is -1.79%, compared to STRM's ROE of -0.65%. Regarding short-term risk, LFMDP is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
LFMDP vs RNLX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas RNLX's P/E ratio is -0.33. In terms of profitability, LFMDP's ROE is -1.79%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, LFMDP is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
LFMDP vs LIFW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas LIFW's P/E ratio is -0.02. In terms of profitability, LFMDP's ROE is -1.79%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, LFMDP is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check LIFW's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
LFMDP vs SCNX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SCNX has a market cap of 18.3M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SCNX trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SCNX's P/E ratio is -0.18. In terms of profitability, LFMDP's ROE is -1.79%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, LFMDP is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SCNX's competition here
Babylon Holdings Limited (NYSE: BBLN)
LFMDP vs BBLN Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas BBLN's P/E ratio is -0.04. In terms of profitability, LFMDP's ROE is -1.79%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, LFMDP is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check BBLN's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
LFMDP vs BFRG Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while BFRG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas BFRG's P/E ratio is -1.27. In terms of profitability, LFMDP's ROE is -1.79%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, LFMDP is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
LFMDP vs ETAO Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas ETAO's P/E ratio is -0.01. In terms of profitability, LFMDP's ROE is -1.79%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, LFMDP is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
LFMDP vs MGRX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, MGRX has a market cap of 7.2M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while MGRX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas MGRX's P/E ratio is -0.31. In terms of profitability, LFMDP's ROE is -1.79%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, LFMDP is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
LFMDP vs UPH-WT Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, LFMDP is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
LFMDP vs UPH Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas UPH's P/E ratio is -0.07. In terms of profitability, LFMDP's ROE is -1.79%, compared to UPH's ROE of -1.05%. Regarding short-term risk, LFMDP is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
LFMDP vs PEARW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas PEARW's P/E ratio is -0.00. In terms of profitability, LFMDP's ROE is -1.79%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, LFMDP is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
LFMDP vs PEAR Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas PEAR's P/E ratio is -0.08. In terms of profitability, LFMDP's ROE is -1.79%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, LFMDP is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
LFMDP vs OTRK Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas OTRK's P/E ratio is -0.02. In terms of profitability, LFMDP's ROE is -1.79%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, LFMDP is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
LFMDP vs CMAX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CMAX's P/E ratio is -0.00. In terms of profitability, LFMDP's ROE is -1.79%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, LFMDP is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check CMAX's competition here
Aclarion, Inc. (NASDAQ: ACON)
LFMDP vs ACON Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while ACON trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas ACON's P/E ratio is -0.30. In terms of profitability, LFMDP's ROE is -1.79%, compared to ACON's ROE of -0.59%. Regarding short-term risk, LFMDP is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check ACON's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
LFMDP vs BFRGW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, LFMDP's ROE is -1.79%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, LFMDP is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check BFRGW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
LFMDP vs LIFWZ Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, LFMDP is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check LIFWZ's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
LFMDP vs HCTI Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, HCTI has a market cap of 1M. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while HCTI trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas HCTI's P/E ratio is -0.11. In terms of profitability, LFMDP's ROE is -1.79%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, LFMDP is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
LFMDP vs VSEEW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, LFMDP's ROE is -1.79%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, LFMDP is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
LFMDP vs MSPRZ Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, LFMDP is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
LFMDP vs VSEE Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, VSEE has a market cap of 447.3K. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while VSEE trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas VSEE's P/E ratio is -0.06. In terms of profitability, LFMDP's ROE is -1.79%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, LFMDP is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERNW)
LFMDP vs KERNW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas KERNW's P/E ratio is -0.00. In terms of profitability, LFMDP's ROE is -1.79%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, LFMDP is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
LFMDP vs KERN Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas KERN's P/E ratio is -0.01. In terms of profitability, LFMDP's ROE is -1.79%, compared to KERN's ROE of -0.20%. Regarding short-term risk, LFMDP is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
LFMDP vs LIFWW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas LIFWW's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, LFMDP is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
LFMDP vs CMAXW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CMAXW's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, LFMDP is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
LFMDP vs ZCMD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, ZCMD has a market cap of 32.2K. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while ZCMD trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, LFMDP's ROE is -1.79%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, LFMDP is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
LFMDP vs ACONW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, ACONW has a market cap of 16K. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas ACONW's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, LFMDP is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBC)
LFMDP vs MTBC Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas MTBC's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, LFMDP is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check MTBC's competition here
Castlight Health, Inc. (NYSE: CSLT)
LFMDP vs CSLT Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CSLT's P/E ratio is -37.27. In terms of profitability, LFMDP's ROE is -1.79%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, LFMDP is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check CSLT's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
LFMDP vs AFFX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas AFFX's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, LFMDP is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
LFMDP vs MTBCO Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas MTBCO's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, LFMDP is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check MTBCO's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
LFMDP vs CHNGU Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CHNGU's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, LFMDP is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CHNGU's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
LFMDP vs KURIU Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas KURIU's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, LFMDP is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check KURIU's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
LFMDP vs MTBCP Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas MTBCP's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, LFMDP is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check MTBCP's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
LFMDP vs CHNG Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CHNG's P/E ratio is -152.72. In terms of profitability, LFMDP's ROE is -1.79%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, LFMDP is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check CHNG's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
LFMDP vs NAVA Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas NAVA's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, LFMDP is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for LFMDP.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
LFMDP vs CERN Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CERN has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CERN's P/E ratio is 55.84. In terms of profitability, LFMDP's ROE is -1.79%, compared to CERN's ROE of +0.14%. Regarding short-term risk, LFMDP is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check CERN's competition here
NantHealth, Inc. (NASDAQ: NH)
LFMDP vs NH Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, NH has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas NH's P/E ratio is -0.12. In terms of profitability, LFMDP's ROE is -1.79%, compared to NH's ROE of +0.35%. Regarding short-term risk, LFMDP is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check NH's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
LFMDP vs CNVY Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas CNVY's P/E ratio is -71.50. In terms of profitability, LFMDP's ROE is -1.79%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, LFMDP is similarly volatile compared to CNVY. This indicates similar risk in terms of short-term price fluctuations for LFMDP.Check CNVY's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
LFMDP vs IMS Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, IMS has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas IMS's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to IMS's ROE of +0.27%. Regarding short-term risk, LFMDP is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check IMS's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
LFMDP vs SMFRW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas SMFRW's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, LFMDP is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SMFRW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
LFMDP vs MSPRV Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.2M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.17 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -714.95, whereas MSPRV's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to MSPRV's ROE of N/A. Regarding short-term risk, LFMDP is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check MSPRV's competition here